Researchers performed studies on 560 critically ill patients with sepsis at Barnes-Jewish Hospital in St. Louis and compared results from 161 critically ill patients without sepsis and 164 healthy outpatient surgery patients, to detect viruses in their bloodstream.
Patients with sepsis had much higher levels of viruses in their blood compared to the groups without sepsis.
“The finding that critically ill patients with sepsis have a number of different viruses circulating in the bloodstream is compelling evidence they are immune-suppressed and dramatically could alter therapy for sepsis,” co-senior author Gregory Storch, MD, a virologist and chief of the Division of Pediatric Infectious Diseases, said in a report.
If the immune system is suppressed, sepsis patients could be unable to fight off other infections, like ventilator-associated pneumonia. Therefore, sepsis patients may benefit from immunotherapy drugs being incorporated into their treatment.
More Articles on Sepsis:
CDC Launches New Sepsis Website
Sepsis Plays Role in Half of All Hospital Deaths, Study Says
Sepsis Patients With C. diff Infections Linked to Increased Mortality, LOS, Cost
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
